Asia: Covid scars and political rivalry


  • 中国,
  • 印度,
  • 印尼,
  • 日本,
  • 马来西亚,
  • 菲律宾,
  • 韩国,
  • 泰国,
  • 越南
  • 一般经济


Asian trade is at a crossroads in the wake of the Covid-19 pandemic and with the US-China trade war ongoing.

Key points:

  • Record numbers of new Covid-19 cases slow the economic recovery in Asia, but only temporarily and mainly in countries with a low percentage of the population that is fully vaccinated.China and Vietnam show highest growth in Asia since the outbreak of Covid-19. India’s economy, despite high growth rates, is likely to experience a setback. Economic activity in Thailand and the Philippines will not reach pre-pandemic levels before 2022.

  • Rising exports are contributing to the recovery in most countries, with Vietnam and China taking advantage of a global boom in demand for computers and electronics.

  • Vietnam will also benefit from the ongoing US-China trade war, with a strong recovery in FDI inflows. The trade war has not resulted in a significant decoupling of the US and Chinese economies.

  • The direct impact of supply chain distortions will disappear, but the pandemic will leave scars with long-term implications for growth and international trade. India and the Philippines will suffer economic scarring the most, while Vietnam and Taiwan probably feel it the least. Differences in the containment of the Covid-19 outbreak and the level of fiscal support are the main explanatory factors.

  • Companies will rethink and redesign their supply chains because of the disruptions that have led to shortages of essential commodities around the world and increased costs. For governments this is, together with the trade war, a reason to place more emphasis on self-reliance in crucial sectors such as high-tech and pharmaceuticals.

  • Free trade agreements offer some counterbalance to these developments. Like trade policy in general, however, they are increasingly tools of geopolitical aspirations and less inspired by the pursuit of economic cooperation.

Bert Burger, senior economist
+31 20 553 2872



Each publication available on or from our websites, such as, but not limited to webpages, reports, articles, publications, tips and helpful content, trading briefs, infographics, videos (each a “Publication”) is provided for information purposes only and is not intended as a recommendation or advice as to particular transactions, investments or strategies in any way to any reader. Readers must make their own independent decisions, commercial or otherwise, regarding the information provided. While we have made every attempt to ensure that the information contained in any Publication has been obtained from reliable sources, Atradius is not responsible for any errors or omissions, or for the results obtained from the use of this information. All information in any Publication is provided ’as is’, with no guarantee of completeness, accuracy, timeliness or of the results obtained from its use, and without warranty of any kind, express or implied. In no event will Atradius, its related partnerships or corporations, or the partners, agents or employees thereof, be liable to you or anyone else for any decision made or action taken in reliance on the information in any Publication, or for any loss of opportunity, loss of profit, loss of production, loss of business or indirect losses, special or similar damages of any kind, even if advised of the possibility of such losses or damages.